NO20074025L - Konjugater for dobbel billeddannelse og radiokjemoterapi:sammensetninger, fremstilling og anvendelse - Google Patents
Konjugater for dobbel billeddannelse og radiokjemoterapi:sammensetninger, fremstilling og anvendelseInfo
- Publication number
- NO20074025L NO20074025L NO20074025A NO20074025A NO20074025L NO 20074025 L NO20074025 L NO 20074025L NO 20074025 A NO20074025 A NO 20074025A NO 20074025 A NO20074025 A NO 20074025A NO 20074025 L NO20074025 L NO 20074025L
- Authority
- NO
- Norway
- Prior art keywords
- dual imaging
- radiochemistry
- conjugates
- compositions
- preparation
- Prior art date
Links
- 230000009977 dual effect Effects 0.000 title abstract 4
- 238000003384 imaging method Methods 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 125000000837 carbohydrate group Chemical group 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N glucosamine group Chemical group OC1[C@H](N)[C@@H](O)[C@H](O)[C@H](O1)CO MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 abstract 1
- 230000003463 hyperproliferative effect Effects 0.000 abstract 1
- 238000001959 radiotherapy Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Birds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64155905P | 2005-01-05 | 2005-01-05 | |
| PCT/US2006/000269 WO2006074272A2 (en) | 2005-01-05 | 2006-01-05 | Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20074025L true NO20074025L (no) | 2007-09-27 |
Family
ID=36648161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20074025A NO20074025L (no) | 2005-01-05 | 2007-08-03 | Konjugater for dobbel billeddannelse og radiokjemoterapi:sammensetninger, fremstilling og anvendelse |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8147805B2 (pt) |
| EP (1) | EP1846042A2 (pt) |
| JP (1) | JP2008531755A (pt) |
| KR (1) | KR101313712B1 (pt) |
| CN (1) | CN101137398B (pt) |
| AU (2) | AU2006204045B2 (pt) |
| BR (1) | BRPI0606395A2 (pt) |
| CA (1) | CA2593256A1 (pt) |
| IL (1) | IL184415A0 (pt) |
| NO (1) | NO20074025L (pt) |
| WO (1) | WO2006074272A2 (pt) |
Families Citing this family (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7067111B1 (en) * | 1999-10-25 | 2006-06-27 | Board Of Regents, University Of Texas System | Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| JP4868698B2 (ja) | 2001-05-02 | 2012-02-01 | パーデュー・リサーチ・ファウンデーション | マクロファージが仲介する疾患の治療および診断 |
| US8043603B2 (en) | 2002-02-07 | 2011-10-25 | Endocyte, Inc. | Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology |
| US8043602B2 (en) | 2002-02-07 | 2011-10-25 | Endocyte, Inc. | Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology |
| ATE412897T1 (de) | 2003-05-30 | 2008-11-15 | Purdue Research Foundation | Diagnoseverfahren für atherosklerose |
| US9050378B2 (en) * | 2003-12-10 | 2015-06-09 | Board Of Regents, The University Of Texas System | N2S2 chelate-targeting ligand conjugates |
| ITMI20040928A1 (it) | 2004-05-07 | 2004-08-07 | Uni Di Bologna Dipartiment O D | Procedura per la preparazione di coniugati della doxorubicina con l'albumina umana lattosaminata |
| CN101128152A (zh) * | 2004-12-23 | 2008-02-20 | 普渡研究基金会 | 发射正电子段层成像方法 |
| US8703097B2 (en) * | 2005-02-11 | 2014-04-22 | University Health Network | Compositions and method for multimodal imaging |
| US9820986B2 (en) * | 2005-03-04 | 2017-11-21 | Taiwan Hopaz Chems, Mfg. Co., Ltd. | Glycopeptide compositions |
| WO2007006041A2 (en) | 2005-07-05 | 2007-01-11 | Purdue Research Foundation | Imaging and therapeutic method using monocytes |
| ITMI20051743A1 (it) * | 2005-09-20 | 2007-03-21 | Uni Di Bologna Dipartimento Di Patologia Spa | Uso di coniugati della doxorubicina con albumina lattosaminata |
| WO2007038346A2 (en) * | 2005-09-23 | 2007-04-05 | Purdue Research Foundation | Multiphoton in vivo flow cytometry method and device |
| WO2007126730A1 (en) * | 2006-03-29 | 2007-11-08 | Isotherapeautics Group Llc | Radionuclide therapy for urinary bladder cancer |
| WO2007120153A1 (en) * | 2006-04-19 | 2007-10-25 | The Board Of Regents Of The University Of Texas System | Compositions and methods for cellular imaging and therapy |
| US10925977B2 (en) * | 2006-10-05 | 2021-02-23 | Ceil>Point, LLC | Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| EP2087337A4 (en) | 2006-11-03 | 2010-09-08 | Purdue Research Foundation | METHOD AND DEVICE FOR EX-VIVO FLOW CYTOMETRY |
| WO2008064040A2 (en) * | 2006-11-22 | 2008-05-29 | The Board Of Regents Of The University Of Texas System | Methods and compositions using chelator-antibody conjugates |
| EP2109466B1 (en) * | 2007-02-07 | 2014-11-12 | Purdue Research Foundation | Positron emission tomography imaging method |
| MX340566B (es) * | 2007-03-27 | 2016-07-14 | Radiomedix Inc | Composiciones para formacion de imagen objetivo y terapia. |
| WO2008148001A2 (en) * | 2007-05-25 | 2008-12-04 | Purdue Research Foundation | Method of imaging localized infections |
| US20120277409A1 (en) * | 2007-06-04 | 2012-11-01 | Board Of Regents, The University Of Texas System | Metal-polysaccharide conjugates: compositions, synthesis and methods for cancer therapy |
| GB0725070D0 (en) * | 2007-12-21 | 2008-01-30 | Iopharma Technologies Ab | Product |
| DE102008045937B4 (de) * | 2008-04-11 | 2017-01-26 | Johannes-Gutenberg-Universität Mainz | Radiopharmakon aus einem Metallion und einem Markierungsvorläufer und Verwendung des Radiopharmakons |
| US20090264753A1 (en) * | 2008-04-22 | 2009-10-22 | General Electric Company | Method & system for multi-modality imaging of sequentially obtained pseudo-steady state data |
| WO2009137428A2 (en) * | 2008-05-05 | 2009-11-12 | Emory University | Methods of determining renal function using technetium-99m tricarbonyl-nitrilotriacetic acid |
| WO2010004464A1 (en) | 2008-07-09 | 2010-01-14 | Koninklijke Philips Electronics N.V. | Physiological pharmacokinetic analysis for combined molecular mri and dynamic pet imaging |
| CN102458442B (zh) * | 2009-04-08 | 2016-06-29 | 加利福尼亚大学董事会 | 具有受控血清药代动力学的人蛋白支架 |
| JP2011063572A (ja) * | 2009-09-18 | 2011-03-31 | Kyushu Univ | 診断用造影剤 |
| KR100991716B1 (ko) * | 2009-10-22 | 2010-11-04 | 경북대학교 산학협력단 | 광학영상 조영제, 그 용도 및 장치 |
| US8547533B2 (en) | 2009-12-28 | 2013-10-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Composite probes and use thereof in super resolution methods |
| KR101395085B1 (ko) * | 2010-06-11 | 2014-05-21 | 국립암센터 | 종양 및 감시림프절에 특이적인 방사성동위원소 표지된 엽산 결합 인혈청 알부민 |
| CN102218150B (zh) * | 2010-08-17 | 2013-01-30 | 扬州大学 | 肝靶向纳米Fe3O4MRI造影剂及制备方法 |
| CN102398026B (zh) * | 2010-09-10 | 2013-10-23 | 聚和国际股份有限公司 | 甲壳素修饰的纳米金粒子及其制造方法 |
| CN102558291B (zh) * | 2010-12-17 | 2014-03-12 | 北京大学人民医院 | 一种双模分子影像探针 |
| US20140199243A1 (en) * | 2011-06-17 | 2014-07-17 | Centre National De La Recherche Scientifique | Bifunctional phosphonate chelating agents |
| CA2843313C (en) | 2011-06-20 | 2018-02-13 | Radiomedix Inc. | Compositions, methods of synthesis and use of carbohydrate targeted agents |
| US10307167B2 (en) | 2012-12-14 | 2019-06-04 | Corquest Medical, Inc. | Assembly and method for left atrial appendage occlusion |
| US10314594B2 (en) | 2012-12-14 | 2019-06-11 | Corquest Medical, Inc. | Assembly and method for left atrial appendage occlusion |
| US10813630B2 (en) | 2011-08-09 | 2020-10-27 | Corquest Medical, Inc. | Closure system for atrial wall |
| AU2012347765B2 (en) * | 2011-12-06 | 2017-05-04 | Research Institute At Nationwide Childrens's Hospital | Non-ionic, low osmolar contrast agents for delivery of antisense oligonucleotides and treatment of disease |
| PT2830666T (pt) * | 2012-03-26 | 2020-04-02 | Univ Texas | Síntese eficiente de conjugados de etilenodicisteína-açúcar para imagiologia e terapia |
| CN104487098B (zh) * | 2012-07-20 | 2017-12-15 | 佳能株式会社 | 光声成像用造影剂 |
| US20140142689A1 (en) | 2012-11-21 | 2014-05-22 | Didier De Canniere | Device and method of treating heart valve malfunction |
| JP6359554B2 (ja) * | 2012-12-12 | 2018-07-18 | ソルベイ スペシャルティ ポリマーズ イタリー エス．ピー．エー． | フッ素化キトサン誘導体 |
| US10035009B2 (en) | 2013-04-15 | 2018-07-31 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for treating pancreatic cancer |
| US9566443B2 (en) | 2013-11-26 | 2017-02-14 | Corquest Medical, Inc. | System for treating heart valve malfunction including mitral regurgitation |
| US9850183B2 (en) | 2014-06-27 | 2017-12-26 | Reiley Pharmaceuticals, Inc. | Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imaging |
| BE1021191B1 (fr) * | 2014-08-29 | 2015-10-27 | Anmi S.A. | Kit pour radiomarquage. |
| US11027030B2 (en) | 2014-08-29 | 2021-06-08 | Anmi S.A. | Kit for radiolabelling |
| US10842626B2 (en) | 2014-12-09 | 2020-11-24 | Didier De Canniere | Intracardiac device to correct mitral regurgitation |
| US10053478B2 (en) | 2015-01-09 | 2018-08-21 | Reiley Pharmaceuticals, Inc. | COX-2-targeting, platinum-containing conjugates and their use in the treatment of tumors and cancers |
| WO2017090047A1 (en) | 2015-11-27 | 2017-06-01 | Technology Innovation Momentum Fund (Israel) Limited Partnership | Glucosamine and derivatives thereof in imaging |
| CN108761078A (zh) * | 2018-05-19 | 2018-11-06 | 复旦大学 | 胰腺癌基底微绒毛的检测方法和应用 |
| IL271681A (en) | 2018-07-18 | 2020-01-30 | Vyripharm Entpr Llc | Systems and methods for integrated and comprehensive management of cannabis products |
| KR20200047322A (ko) | 2018-10-26 | 2020-05-07 | 전남대학교병원 | 체내위치확인 시스템 |
| CN114555131A (zh) * | 2019-08-19 | 2022-05-27 | 纳维迪亚生物制药有限公司 | 用于消融m2巨噬细胞和髓源性抑制细胞的组合物和相关方法 |
| CN110563859B (zh) * | 2019-09-19 | 2021-07-23 | 湖北医药学院 | 抗肝癌药物亚硒酸酯化壳聚糖铜的一锅合成法及应用 |
| CN110981940A (zh) * | 2019-11-08 | 2020-04-10 | 复旦大学附属肿瘤医院 | 一种pd-l1结合剂、金属配合物及其使用方法和用途 |
| DE102019135564B4 (de) * | 2019-12-20 | 2022-05-19 | Johannes-Gutenberg-Universität Mainz | Verbindung für Smart-Drug-Delivery und pharmazeutisches Kit für duale nuklearmedizinisch-cytotoxische Theranostik |
| CN120550144A (zh) * | 2020-12-28 | 2025-08-29 | 波士顿科学医学有限公司 | 具有改善的放射性造影特性的多糖 |
| US20220305146A1 (en) * | 2021-03-26 | 2022-09-29 | Vyripharm Enterprises, Inc. | Radiopharmaceutical compositions and methods for infectious disease diagnosis and therapy |
| WO2023201377A2 (en) * | 2022-04-15 | 2023-10-19 | The General Hospital Corporation | Scission-enhanced nuclear imaging and treatment |
| CN116655928B (zh) * | 2023-04-18 | 2025-08-29 | 扬州大学 | 一种基于半胱氨酸的超分子手性光热剂及其应用 |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE465907B (sv) * | 1984-11-01 | 1991-11-18 | Nyegaard & Co As | Diagnosticeringsmedel innehaallande en paramagnetisk metall |
| US4861869A (en) * | 1986-05-29 | 1989-08-29 | Mallinckrodt, Inc. | Coupling agents for joining radionuclide metal ions with biologically useful proteins |
| US5707604A (en) * | 1986-11-18 | 1998-01-13 | Access Pharmaceuticals, Inc. | Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles |
| CA1340556C (en) * | 1986-12-30 | 1999-05-25 | Komei Washino | High molecular compound comprising unit of asialoglyco-protein acceptor-directing compound and unit of chelate-forming compound chemically bonded thereto, and its utilization |
| US4965392A (en) * | 1987-03-26 | 1990-10-23 | Neorx Corporation | Chelating compounds for metal-radionuclide labeled proteins |
| US5364613A (en) * | 1989-04-07 | 1994-11-15 | Sieving Paul F | Polychelants containing macrocyclic chelant moieties |
| US5116599A (en) * | 1989-07-31 | 1992-05-26 | Johns Hopkins Univ. | Perfluoro-t-butyl-containing compounds for use in fluorine-19 nmr and/or mri |
| WO1991016076A1 (en) * | 1990-04-17 | 1991-10-31 | Mallinckrodt Medical, Inc. | Method and kit for preparing technetium-99m complexes |
| CA2084315A1 (en) * | 1990-06-01 | 1991-12-02 | Institut Fur Diagnostikforschung Gmbh An Der Freien Universitat Berlin | Cyclopentadienylcarbonyl 99m tc complexes, process for their production as well as their use in diagnostics |
| CA2089519C (en) * | 1990-08-17 | 2000-01-11 | Kazuhiro Inoue | N-acetylcarboxymethylchitosan derivatives and process for preparation thereof |
| JP2894879B2 (ja) * | 1991-10-04 | 1999-05-24 | 日本メジフィジックス株式会社 | 診断用造影剤 |
| WO1994005203A1 (en) * | 1992-09-04 | 1994-03-17 | The General Hospital Corporation | Biocompatible polymers containing diagnostic or therapeutic moieties |
| US5605672A (en) | 1993-06-09 | 1997-02-25 | The General Hospital Corporation | Blood pool imaging composition and method of its use |
| US5840332A (en) * | 1996-01-18 | 1998-11-24 | Perio Products Ltd. | Gastrointestinal drug delivery system |
| US5955053A (en) * | 1996-05-06 | 1999-09-21 | Emory University | Metal chelates as pharmaceutical imaging agents, processes of making such and uses thereof |
| US5986074A (en) * | 1996-05-06 | 1999-11-16 | Emory University | Metal chelates as pharmaceutical imaging agents, processes of making such and uses thereof |
| US5900228A (en) * | 1996-07-31 | 1999-05-04 | California Institute Of Technology | Bifunctional detection agents having a polymer covalently linked to an MRI agent and an optical dye |
| JP2001519379A (ja) * | 1997-10-09 | 2001-10-23 | ペリオ、プロダクツ、リミテッド | 遅延性総放出胃腸薬物送達システム |
| WO1999020316A1 (en) * | 1997-10-20 | 1999-04-29 | Board Of Regents, The University Of Texas System | Single photon-emitting radiotraces and methods for their use |
| AU3870099A (en) * | 1998-04-28 | 1999-11-16 | Jagotec Ag | Hyaluronan-based imaging agents |
| ATE393171T1 (de) * | 1998-11-10 | 2008-05-15 | Netech Inc | Funktionelle chitosanderivate |
| US7067111B1 (en) * | 1999-10-25 | 2006-06-27 | Board Of Regents, University Of Texas System | Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| US6692724B1 (en) * | 1999-10-25 | 2004-02-17 | Board Of Regents, The University Of Texas System | Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| US6399951B1 (en) * | 2000-02-02 | 2002-06-04 | Ut-Battelle, Llc | Simultaneous CT and SPECT tomography using CZT detectors |
| CA2406852A1 (en) * | 2000-04-20 | 2001-11-01 | The University Of British Columbia | Radiometal complexes of 2-pyrrolylthiones and their use as radiopharmaceuticals for imaging and therapy |
| HUP0400758A3 (en) * | 2000-11-03 | 2005-02-28 | Bristol Myers Squibb Pharma Co | Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| US6623721B2 (en) * | 2000-12-18 | 2003-09-23 | Draximage, Inc. | Bifunctional chelating compounds containing hydroxamic acid residues |
| US20030003048A1 (en) * | 2001-04-26 | 2003-01-02 | Chun Li | Diagnostic imaging compositions, their methods of synthesis and use |
| GB0111204D0 (en) | 2001-05-08 | 2001-06-27 | Mertek Ltd | High flux,high energy photon source |
| US7112340B2 (en) * | 2001-10-19 | 2006-09-26 | Baxter International Inc. | Compositions of and method for preparing stable particles in a frozen aqueous matrix |
| US7138105B2 (en) * | 2002-02-27 | 2006-11-21 | Pharmain | Compositions for delivery of therapeutics and other materials, and methods of making and using the same |
| WO2003082301A1 (en) * | 2002-03-29 | 2003-10-09 | Threshold Pharmaceuticals, Inc. | Compositions and methods for treating cancer |
| JP2005531647A (ja) * | 2002-04-11 | 2005-10-20 | カルボマー インク | 新規なイメージングプローブ |
| US20040022729A1 (en) * | 2002-07-31 | 2004-02-05 | Uzgiris Egidijus E. | Method for binding molecular agents to angiogencic blood vessels |
| US20040042959A1 (en) * | 2002-08-28 | 2004-03-04 | Michael Montalto | Imaging cell death in vivo using non-radionuclide contrast agents |
| US7303741B2 (en) | 2002-09-23 | 2007-12-04 | General Electric Company | Systems and methods for high-resolution in vivo imaging of biochemical activity in a living organism |
| KR101086690B1 (ko) * | 2002-11-07 | 2011-11-25 | 셀>포인트, 엘엘씨 | 에틸렌디시스테인（ｅｃ）－약물 콘쥬게이트, 조성물 및조직 특이적 질환 영상 방법 |
| US20050024380A1 (en) * | 2003-07-28 | 2005-02-03 | Lin Lin | Method for reducing random access memory of IC in display devices |
| US7790141B2 (en) * | 2003-08-11 | 2010-09-07 | Pathak Holdings, Llc | Radio-opaque compounds, compositions containing same and methods of their synthesis and use |
| US9050378B2 (en) * | 2003-12-10 | 2015-06-09 | Board Of Regents, The University Of Texas System | N2S2 chelate-targeting ligand conjugates |
| EP1743174B1 (en) * | 2004-04-20 | 2013-03-20 | Emory University | Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof |
-
2006
- 2006-01-05 BR BRPI0606395-0A patent/BRPI0606395A2/pt not_active IP Right Cessation
- 2006-01-05 US US11/326,117 patent/US8147805B2/en active Active
- 2006-01-05 AU AU2006204045A patent/AU2006204045B2/en not_active Ceased
- 2006-01-05 CN CN200680005698XA patent/CN101137398B/zh not_active Expired - Lifetime
- 2006-01-05 JP JP2007550450A patent/JP2008531755A/ja active Pending
- 2006-01-05 EP EP06733616A patent/EP1846042A2/en not_active Withdrawn
- 2006-01-05 WO PCT/US2006/000269 patent/WO2006074272A2/en not_active Ceased
- 2006-01-05 KR KR1020077018015A patent/KR101313712B1/ko not_active Expired - Lifetime
- 2006-01-05 CA CA002593256A patent/CA2593256A1/en not_active Abandoned
-
2007
- 2007-07-04 IL IL184415A patent/IL184415A0/en unknown
- 2007-08-03 NO NO20074025A patent/NO20074025L/no not_active Application Discontinuation
-
2011
- 2011-01-13 AU AU2011200132A patent/AU2011200132B2/en not_active Expired
-
2012
- 2012-04-03 US US13/438,641 patent/US20120276005A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2593256A1 (en) | 2006-07-13 |
| KR20070106711A (ko) | 2007-11-05 |
| KR101313712B1 (ko) | 2013-10-01 |
| US20060182687A1 (en) | 2006-08-17 |
| US20120276005A1 (en) | 2012-11-01 |
| JP2008531755A (ja) | 2008-08-14 |
| IL184415A0 (en) | 2008-12-29 |
| BRPI0606395A2 (pt) | 2009-06-23 |
| AU2011200132B2 (en) | 2012-10-11 |
| AU2006204045B2 (en) | 2010-10-14 |
| WO2006074272A8 (en) | 2006-12-28 |
| AU2011200132A1 (en) | 2011-02-03 |
| US8147805B2 (en) | 2012-04-03 |
| EP1846042A2 (en) | 2007-10-24 |
| CN101137398B (zh) | 2012-07-04 |
| WO2006074272A3 (en) | 2007-05-31 |
| CN101137398A (zh) | 2008-03-05 |
| AU2006204045A1 (en) | 2006-07-13 |
| WO2006074272A2 (en) | 2006-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20074025L (no) | Konjugater for dobbel billeddannelse og radiokjemoterapi:sammensetninger, fremstilling og anvendelse | |
| WO2008045604A3 (en) | Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications | |
| AU2006226733A8 (en) | Antibodies against CD38 for treatment of multiple myeloma | |
| PH12023550266A1 (en) | Anti-ceacam5 antibodies and conjugates and uses thereof | |
| MX2010005022A (es) | Anticuerpos que unen celulas dendriticas y epiteliales 205 (dec-205) humanas. | |
| WO2007073499A3 (en) | Epha2 bite molecules and uses thereof | |
| DE60323756D1 (de) | Pharmazeutisch aktive oligosaccharid-conjugate | |
| NO20073790L (no) | Kjemiske forbindelser | |
| NO20073788L (no) | Kjemiske forbindelser | |
| TW200716606A (en) | Chemical compounds | |
| TW200800963A (en) | Chemical compounds | |
| TW200700093A (en) | Pharmaceutical composition for the treatment of cancer | |
| WO2005103081A3 (en) | Human monoclonal antibodies against cd20 | |
| UA92505C2 (ru) | Композиции на основе антитела против cd3 | |
| IL176007A0 (en) | Antibodies specific to c35 and pharmaceutical compositions containing the same | |
| BR112021025720A2 (pt) | Conjugados anticorpo-fármaco de fator antitecido e métodos relacionados | |
| WO2011028334A3 (en) | Synthesis and isolation of dendrimer systems | |
| CY1111256T1 (el) | Παραγωγα αζαδικυκλοοκταν-3-ονης και χρηση τους | |
| UA99602C2 (ru) | Антитело, специфически связывающееся с jam-a, способное ингибировать пролиферацию опухолевых клеток | |
| NO20084821L (no) | Formuleringer og metoder for celleimaging og terapi | |
| EA201100565A1 (ru) | Композиции и способы лечения заболеваний кишечника с использованием гранулированного мезаламина | |
| WO2011112566A3 (en) | Basigin binding proteins | |
| WO2009013358A3 (en) | Polysaccharides grafted by polyamines for the preparation of radiopharmaceutical compositions | |
| GB0412019D0 (en) | Organic compounds | |
| WO2023017101A3 (en) | Diphosphine compounds and complexes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |